Scald
Conditions
Interventions
Control group:Placebo and moist wound healing
Experimental group:Platelet-rich plasma (PRP) and moist wound healing
Sponsors
Foshan Maternal and Child Health Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The children all suffered burns with an area >=5%, and on the 3rd day after injury, the wound depth was assessed as deep II°; 2. The wound is at the site of the initial injury, without scars, birthmarks, hemangiomas, or other lesions affecting skin color or marks; 3. The children are aged 1-6 years, with no coexisting organ injuries, such as inhalation injuries to the respiratory tract, and no rheumatic autoimmune diseases, skin diseases, nutritional deficiencies, or other conditions; 4. The family accepts the treatment plan, and the children tolerate the treatment.
Exclusion criteria
Exclusion criteria: 1. The wound has clearly met the criteria for skin grafting during the treatment process; 2. During the treatment, it is newly discovered that the patient has a primary skin disease, rheumatic immune disease, or other conditions that are unknown or concealed by the family; 3. During the treatment, the patient develops an allergic reaction to dressings, platelet-rich plasma, etc.; 4. The family does not accept this treatment plan or does not agree to the collection of data by the research group.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hypertrophic scarring;Wound epithelialization time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total hospitalization cost;Wound infection status.;Hospital stays;Pain assessment; | — |
Countries
China
Contacts
Public ContactYihua Tan
Foshan Maternal and Child Health Hospital
Outcome results
None listed